Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 231-548-0 | CAS number: 7631-90-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics in vitro / ex vivo
- Type of information:
- read-across based on grouping of substances (category approach)
- Adequacy of study:
- key study
- Justification for type of information:
- see attachment “Read-across concept – Human Health/Environment - Category approach for Inorganic sulfites/thiosulfates/dithionite" in section 13.
Data source
Reference
- Reference Type:
- publication
- Title:
- Alternative pathways of sulfite oxidation in human polymorphonuclear leukocytes
- Author:
- Constantin, D. et al.
- Year:
- 1 994
- Bibliographic source:
- Pharmacology & Toxicology. 74: 136 - 140.
Materials and methods
- Objective of study:
- metabolism
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- In the present study, the oxidation of sulfite in human polymorphonuclear leukocytes was investigated and the sulfite-oxidase catalyzed reaction and the non-enzymatic pathway were compared.
- GLP compliance:
- not specified
Test material
- Reference substance name:
- Sodium sulphite
- EC Number:
- 231-821-4
- EC Name:
- Sodium sulphite
- Cas Number:
- 7757-83-7
- Molecular formula:
- NA2SO3
- IUPAC Name:
- disodium sulfite
- Test material form:
- not specified
- Details on test material:
- - Name of test material (as cited in study report): Sodium sulfite
Constituent 1
- Radiolabelling:
- no
Test animals
- Species:
- human
- Details on test animals or test system and environmental conditions:
- Not applicable - Since this is a in vitro study there is no information on test animals.
Administration / exposure
- Route of administration:
- other: human polymorphonuclear leukocytes
- Duration and frequency of treatment / exposure:
- Cell culture used: Human polymorphonuclear leukocytes were isolated from buffy coat (obtained from the Blood Donor center of Sabbatsbergs Hospital, Stockholm, Sweden).
(For further information on the preparation on the human polymorphonuclear leukocytes see "Any other information on materials and method incl. tables" below.)
Doses / concentrations
- Remarks:
- For information on the preparation on the human polymorphonuclear leukocytes see "Any other information on materials and method incl. tables" below.
- No. of animals per sex per dose / concentration:
- Not appropriate
- Statistics:
- The results are expressed as means +/- S.E.M. Groups of data were compared for significant differences using the non-paired t-test.
Results and discussion
Main ADME results
- Type:
- metabolism
- Results:
- Two different oxidation routes of sulfite to sulfate have been identified in the human polymorphonuclear leukocytes. 1. Via sulfite oxidase and 2. via an one electron oxidation step with an intermediate formation of sulfur trioxide radicals.
Metabolite characterisation studies
- Metabolites identified:
- yes
- Details on metabolites:
- Addition of sulfite to polymorphonuclear leukocytes significantly stimulated the uptake of oxygen.
The oxygen consumption varied substantially between cells from different donors and were divided in those with low (0 -200 nmol O2/ml/min.) and high (>200 nmol O2/ml/min.) capacity.
The interindividual difference in oxygen uptake was also reflected in the rates of sulfite disappearance and sulfate formation, the correlation between these two parameters being fairly good. The correlation was not affected by varying the concentration of sulfite added to the leukocytes. It is assumed that the variation in oxygen consumption mainly reflects the cells capacity to oxidize sulfite direct to sulfate, thus the activity of sulfite oxidase.
Only 30 % to 40% of the sulfite added to cells with low sulfite oxidase activity was oxidized to sulfate after 30 min. incubation whereas on average about 60% was oxidized in cells with high activity.
In the presence of sulfite, addition of phorbol myristate acetate to cells with low sulfite oxidase activity increased the O2 consumption substantially (up to 600 nmol/ml/ min.) In cells with high enzyme activity an inhibitory effect of phorbol myristate acetate on oxygen consumption was observed.
The effect of phorbol myristate acetate can also be seen on the oxidation of sulfite to sulfate. In cells with low sulfite oxidase activity the addition of phorbol myriastate acetate increases the rate of sulfate formation whereas in cells with high activity phorbol myriastate acetate has an inhibitory effect.
The EPR spectrum shows signals consistent with the presence of sulfur trioxide radicals formed during autooxidation of sulfite. A similar spectrum is observed after addition of sulfite to non-phorbol myristate acetate stimulated human polymorphonuclear leukocytes.
When phorbol myristate was added to polymorphonuclear leukocytes and sulfite, an EPR spectrum compatible with the presence of sulfur trioxide radicals as well as hydroxyl adducts with DMPO is observed.
Any other information on results incl. tables
The interaction of sulfite and the superoxide radical anion (O2^-) formed during the oxidative burst in the leukocytes was also investigated. The formation of O2^- was estimated by measuring the reduction of cytochrome C. Sulfite efficiently inhibited the reduction of cytochrome C by cells with low sulfite oxidase activity. For instance in the presence of 1 mM sulfite the inhibition was more than 80%. The reason is possible an interaction between O2^- and sulfite leading to sulfur trioxide radical formation. The effect on cytochrome C reduction by sulfite in leukocytes with high sulfite oxidase activity is minor. Due to the very rapid enzymatic oxidation of sulfite to sulfate only limited interction between sulfite and O2^- occurred.
Applicant's summary and conclusion
- Conclusions:
- Two different oxidation routes of sulfite to sulfate have been identified in the human polymorphonuclear leukocytes. Besides the pathway via sulfite oxidase another route of oxidation via an one electron oxidation step with an intermediate formation of sulfur trioxide radicals has been identified.
The contribution of the different pathways is expected to vary substantially due to the great interindividual variation in sulfite oxidase activity. The contribution of the trioxide radical pathway is expected to be high in individuals with low sulfite oxidase activity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.